Quoin Pharmaceuticals Ltd. Restricted Cash And Cash Equivalents
Quoin Pharmaceuticals Ltd. (QNRX) had Restricted Cash And Cash Equivalents of ILS 322.00 thousand as of 2021-06-30, per its 6-K filed 2021-08-24.
Discontinued › Notes
ifrs-full:RestrictedCashAndCashEquivalents · last filed 2021-08-24
- 2021-06-30: Restricted Cash And Cash Equivalents 322.00K ILS.
- 2020-12-31: Restricted Cash And Cash Equivalents 322.00K ILS.
- 2020-06-30: Restricted Cash And Cash Equivalents 330.00K ILS.
- 2019-12-31: Restricted Cash And Cash Equivalents 328.00K ILS.
ILS
| Period end | Restricted Cash And Cash Equivalents |
|---|---|
| 2021-06-30 | 322.00K ILS 6-K · filed 2021-08-24 |
| 2020-12-31 | 322.00K ILS 6-K · filed 2021-08-24 |
| 2020-06-30 | 330.00K ILS 6-K/A · filed 2021-02-11 |
| 2019-12-31 | 328.00K ILS 20-F · filed 2021-03-29 |
| 2019-06-30 | 331.00K ILS 6-K · filed 2019-08-13 |
| 2018-12-31 | 337.00K ILS 20-F · filed 2020-04-03 |
| 2018-06-30 | 333.00K ILS 6-K · filed 2018-08-09 |
| 2017-12-31 | 305.00K ILS 20-F · filed 2019-03-18 |
| 2016-12-31 | 140.00K ILS 20-F · filed 2018-03-19 |
USD
| Period end | Restricted Cash And Cash Equivalents |
|---|---|
| 2021-06-30 | $99.00K 6-K · filed 2021-08-24 |
| 2020-12-31 | $100.00K 20-F · filed 2021-03-29 |
| 2019-12-31 | $95.00K 20-F · filed 2020-04-03 |
| 2018-06-30 | $91.00K 6-K · filed 2018-08-09 |
| 2017-12-31 | $88.00K 20-F · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |